EE200300502A - Use of cationic dextran derivatives to protect dose limiting organs - Google Patents

Use of cationic dextran derivatives to protect dose limiting organs

Info

Publication number
EE200300502A
EE200300502A EEP200300502A EEP200300502A EE200300502A EE 200300502 A EE200300502 A EE 200300502A EE P200300502 A EEP200300502 A EE P200300502A EE P200300502 A EEP200300502 A EE P200300502A EE 200300502 A EE200300502 A EE 200300502A
Authority
EE
Estonia
Prior art keywords
protect
dose limiting
dextran derivatives
cationic dextran
limiting organs
Prior art date
Application number
EEP200300502A
Other languages
Estonian (et)
Inventor
Holmberg Anders
Hiltunen Jukka
Paganelli Giovanni
Cremonesi Marta
Original Assignee
Map Medical Technologies Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Map Medical Technologies Oy filed Critical Map Medical Technologies Oy
Publication of EE200300502A publication Critical patent/EE200300502A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200300502A 2001-04-11 2002-04-11 Use of cationic dextran derivatives to protect dose limiting organs EE200300502A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20010764A FI20010764A0 (en) 2001-04-11 2001-04-11 Cationic dextran derivatives for use in renal protection
PCT/FI2002/000305 WO2002083154A1 (en) 2001-04-11 2002-04-11 Use of cationic dextran derivatives for protecting dose-limiting organs

Publications (1)

Publication Number Publication Date
EE200300502A true EE200300502A (en) 2003-12-15

Family

ID=8560975

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300502A EE200300502A (en) 2001-04-11 2002-04-11 Use of cationic dextran derivatives to protect dose limiting organs

Country Status (13)

Country Link
EP (1) EP1383517A1 (en)
JP (1) JP2004525181A (en)
KR (1) KR20040018350A (en)
BR (1) BR0208860A (en)
CA (1) CA2443052A1 (en)
EE (1) EE200300502A (en)
FI (1) FI20010764A0 (en)
HU (1) HUP0401386A3 (en)
IL (1) IL158153A0 (en)
NO (1) NO20034561L (en)
PL (1) PL363024A1 (en)
RU (1) RU2003132683A (en)
WO (1) WO2002083154A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8685458B2 (en) 2009-03-05 2014-04-01 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives
ES2873502T3 (en) 2009-03-27 2021-11-03 Bend Res Inc Spray drying process
PT2611529T (en) 2010-09-03 2019-05-09 Bend Res Inc Spray-drying method
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
PT2611530T (en) 2010-09-03 2019-05-09 Bend Res Inc Spray-drying apparatus and methods of using the same
WO2012040502A1 (en) 2010-09-24 2012-03-29 Bend Research, Inc. High-temperature spray drying process and apparatus
US9060938B2 (en) 2011-05-10 2015-06-23 Bend Research, Inc. Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
DE102014016901B4 (en) * 2014-09-17 2021-08-12 Friedrich-Schiller-Universität Jena Process for the production of new dextran derivatives as active ingredient carrier systems and their use
CN110023755A (en) * 2016-12-01 2019-07-16 诺伯特·格雷茨 Visible apparatus and method for institutional framework
IL293883A (en) * 2019-12-14 2022-08-01 Manu Chaudhary Formulations of polybasic drugs to reduce multi-organ toxicity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3414491A1 (en) * 1984-04-17 1985-10-24 Hans Dr. 8202 Bad Aibling Dietl L-Amino acid mixtures for parenteral and oral use for kidney disorders
US5290538A (en) * 1988-12-22 1994-03-01 Skrezek Christian Nephro protective infusion solutions
SE9803482D0 (en) * 1998-10-13 1998-10-13 Anders Holmberg Ion exchange tumor targeting (IETT)
WO2001005383A2 (en) * 1999-07-16 2001-01-25 Mallinckrodt, Inc. Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine

Also Published As

Publication number Publication date
WO2002083154A1 (en) 2002-10-24
NO20034561L (en) 2003-12-09
RU2003132683A (en) 2005-04-10
EP1383517A1 (en) 2004-01-28
HUP0401386A3 (en) 2005-06-28
JP2004525181A (en) 2004-08-19
KR20040018350A (en) 2004-03-03
BR0208860A (en) 2004-10-19
HUP0401386A2 (en) 2004-12-28
FI20010764A0 (en) 2001-04-11
NO20034561D0 (en) 2003-10-10
IL158153A0 (en) 2004-03-28
PL363024A1 (en) 2004-11-15
CA2443052A1 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
NO20015112L (en) Use of glycosylceramide synthesis inhibitors in therapy
CY2015003I1 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CANCER
NO20044402L (en) Combination therapy of chemokine-mediated diseases
NO20014858L (en) Use of CYP2D6 inhibitors in combination therapy
CY2014019I1 (en) PHENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
NO20021400D0 (en) Therapeutic conazoline derivatives
NO20033594D0 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
DK1419150T3 (en) 1-Phenylsulfonyl-1,3-dihydro-2H-indol-2-one derivatives, their preparation and their therapeutic use
NO20052894D0 (en) 4-tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
IS6891A (en) Methods for administering epothilone analogues to treatment cancer
EE200200571A (en) Hydroxyphenylpiperidine-4-ylidenemethylbenzamide derivatives for the treatment of pain
NO20041214L (en) Substituted benzimidazole compounds and their use in the treatment of cancer
EE200300502A (en) Use of cationic dextran derivatives to protect dose limiting organs
DE60223576D1 (en) SKIN TREATMENT COMPOSITION
EE200100623A (en) Therapeutic Use of Melatonin
PT1286986E (en) QUINOLYL-PIPERIDIN-4-ILIDENE-METHYL-BENZAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN
EE200200511A (en) Hydroxyphenylpiperazinylmethylbenzamide derivatives for the treatment of pain
DE60222664D1 (en) SKIN TREATMENT AGENT
NO20033341D0 (en) Methods for administering epothilone analogues for the treatment of cancer
EE200300466A (en) Use of pyridoindolone derivatives in the preparation of medicaments
ATE538388T1 (en) INHIBITION OF TRISTETRAPROLINE TO PROTECT HEART DISEASE
NO20041320L (en) Use of specific dose of fondaparinux sodium for the treatment of ACS
ITMI20011820A0 (en) TREATMENT OF BURNS
NO20023243D0 (en) New therapeutic use of enoxaparin
NO20042166L (en) Combination therapy for the treatment of disease